US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Ongoing

Artisan of Skin

Reason Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.

Private Label Skin Care Inc. D-0663-2025
Class II · Moderate risk Ongoing

Major ChlorproMAZINE Hydrochloride Tablets

Reason CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories NDC 0904-7133-61 D-0013-2026
Class II · Moderate risk Ongoing

Major ChlorproMAZINE Hydrochloride Tablets

Reason CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories NDC 0904-7132-61 D-0012-2026
Class II · Moderate risk Ongoing

Major ChlorproMAZINE Hydrochloride Tablets

Reason CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories NDC 0904-7131-61 D-0011-2026
Class II · Moderate risk Ongoing

Major ChlorproMAZINE Hydrochloride Tablets

Reason CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories NDC 0904-7130-61 D-0010-2026
Class II · Moderate risk Ongoing

Major ChlorproMAZINE Hydrochloride Tablets

Reason CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories NDC 0904-7130-06 D-0009-2026
Class II · Moderate risk Ongoing

Ketorolac Tromethamine Ophthalmic Solution

Reason Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns

Apotex Corp. NDC 60505-1003-1 D-0677-2025
Class II · Moderate risk Ongoing

Cyclophosphamide Injection 500 mg/5 mL

Reason cGMP deviations: Temperature excursion during transportation.

Sandoz Inc NDC 0781-3528-75 D-0651-2025
Class II · Moderate risk Ongoing

Entecavir Tablets

Reason Failed Impurity/Degradation Specifications

Zydus Pharmaceuticals (USA) Inc NDC 68382-921-06 D-0657-2025
Class II · Moderate risk Ongoing

Entecavir Tablets

Reason Failed Impurity/Degradation Specifications

Zydus Pharmaceuticals (USA) Inc NDC 68382-920-06 D-0656-2025
Class II · Moderate risk Ongoing

Kit for the Preparation of Technetium Tc 99m Mertiatide

Reason Failed Dissolution Specifications-Out of Specification (OOS) observation for sulphate in Sodium Tartrate Dihydrate used for the production of Mertiatide.

Sun Pharmaceutical Industries INC NDC 45567-0655-1 D-0658-2025
Class II · Moderate risk Ongoing

Chlorpromazine Hydrochloride Tablets

Reason CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

Zydus Pharmaceuticals (USA) Inc D-0639-2025
Class II · Moderate risk Ongoing

Chlorpromazine Hydrochloride Tablets

Reason CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

Zydus Pharmaceuticals (USA) Inc D-0638-2025
Class II · Moderate risk Ongoing

Chlorpromazine Hydrochloride Tablets

Reason CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

Zydus Pharmaceuticals (USA) Inc D-0637-2025
Class II · Moderate risk Ongoing

Chlorpromazine Hydrochloride Tablets

Reason CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

Zydus Pharmaceuticals (USA) Inc D-0636-2025
Class II · Moderate risk Ongoing

Chlorpromazine Hydrochloride Tablets

Reason CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

Zydus Pharmaceuticals (USA) Inc D-0635-2025
Class II · Moderate risk Ongoing

Chlorpromazine Hydrochloride Tablets

Reason CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

Zydus Pharmaceuticals (USA) Inc D-0634-2025
Class II · Moderate risk Ongoing

Chlorpromazine Hydrochloride Tablets

Reason CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

Zydus Pharmaceuticals (USA) Inc D-0633-2025
Class II · Moderate risk Ongoing

Chlorpromazine Hydrochloride Tablets

Reason CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

Zydus Pharmaceuticals (USA) Inc D-0632-2025
Class II · Moderate risk Ongoing

Chlorpromazine Hydrochloride Tablets

Reason CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

Zydus Pharmaceuticals (USA) Inc D-0631-2025
Class II · Moderate risk Ongoing

Chlorpromazine Hydrochloride Tablets

Reason CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

Zydus Pharmaceuticals (USA) Inc D-0630-2025
Class II · Moderate risk Ongoing

Viorele

Reason Failed Impurities/Degradation Specifications

Glenmark Pharmaceuticals Inc., USA NDC 68462-318-29 D-0021-2026
Class II · Moderate risk Ongoing

Sulfamethoxazole and Trimethoprim

Reason Presence of a Foreign Substance: A specific lot of auxiliary polyester coil, used in product packaging by manufacturer (Amneal Pharmaceuticals LLC) was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories NDC 55154-7895-0 D-0625-2025
Class II · Moderate risk Ongoing

Sulfamethoxazole and Trimethoprim

Reason Presence of a Foreign Substance: A specific lot of auxiliary polyester coil, used in product packaging by manufacturer (Amneal Pharmaceuticals LLC) was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories NDC 0904-2725-61 D-0624-2025